HOME
Vol , Issue
Date of Publication: June 30, 2016
DOI: https://doi.org/10.20529/IJME.2016.039
Views
, PDF Downloads:
Editorials
Response to proposed research to reverse brain death: more than regulatory failure
Abstract:
In early May 2016, reports of a bizarre study to attempt a reversal of brain death made the headlines, but there was not even a squeak from the authorities. The "Reanima Project" is a collaboration between an Indian surgeon, Himanshu Bansal, and a US-based biotech company, Bioquark Inc. The research will be conducted by Bansal's own biotech company, Revita Life Sciences, at his Anupam hospital in Rudrapur, a city in Uttarakhand state.
Copyright and license ©Indian Journal of Medical Ethics 2016: Open Access and Distributed under the Creative Commons license ( CC BY-NC-ND 4.0), which permits only non-commercial and non-modified sharing in any medium, provided the original author(s) and source are credited.
